[1]
Curtis, J.R., Elewaut, D., Chen, S., Hojnik, M., Naveh, N. and Anderson, J.K. 2017. Incidence of Inflammatory Bowel Disease Events in Adalimumab Clinical Trials Across Indications. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s18. DOI:https://doi.org/10.25251/skin.1.supp.17.